Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-025296
Date:2019-04-16
Issuer: GENOMIC HEALTH INC (GHDX)
Original Submission Date:

Reporting Person:

FLANNELLY BARRY P
1801 AUGUSTINE CUT-OFF
WILMINGTON, DE 19803

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
DIRECTOR STOCK OPTION (RIGHT TO BUY) 65.2 2019-04-16 deemed execution date A 20,000 (a) 2029-04-16 common stock 0 $65.20 20,000 direct
Footnotes
IDfootnote
f1 the option becomes exercisable as to 25% of the shares on april 16, 2020, and becomes exercisable as to 1/48th of the shares each full month thereafter.
WhaleWisdom Logo

Elevate your investments